Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer

BACKGROUND: The addition of oxaliplatin to adjuvant 5-fluorouracil (5-FU) improves survival of patients with stage III colon cancer in randomized clinical trials (RCTs). However, RCT participants are younger, healthier, and less racially diverse than the general cancer population. Thus, the benefit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sanoff, Hanna K., Carpenter, William R., Martin, Christopher F., Sargent, Daniel J., Meyerhardt, Jeffrey A., Stürmer, Til, Fine, Jason P., Weeks, Jane, Niland, Joyce, Kahn, Katherine L., Schymura, Maria J., Schrag, Deborah
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3274510/
https://ncbi.nlm.nih.gov/pubmed/22266473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr524
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi